Reappraisal of microscopic microsurgical transsphenoidal surgery for GH-secreting pituitary macroadenoma in patients with acromegaly: Historical data from Vietnam (2010–2013)

Objective: In Vietnam, microscopic transsphenoidal surgery has been implemented to treat acromegaly patients since 2000. However, no specific outcome studies have been conducted. We assess outcomes of this technique and factors associated with remission. Methods: This prospective observational study...

Full description

Bibliographic Details
Main Authors: Ngo Manh Hung, Dong Van He, Vu Duy Kien
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:Interdisciplinary Neurosurgery
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214751920303728
_version_ 1818262155360731136
author Ngo Manh Hung
Dong Van He
Vu Duy Kien
author_facet Ngo Manh Hung
Dong Van He
Vu Duy Kien
author_sort Ngo Manh Hung
collection DOAJ
description Objective: In Vietnam, microscopic transsphenoidal surgery has been implemented to treat acromegaly patients since 2000. However, no specific outcome studies have been conducted. We assess outcomes of this technique and factors associated with remission. Methods: This prospective observational study was conducted in 43 patients with acromegaly resulting from Growth Hormone (GH)-secreting pituitary macroadenoma. The primary outcome of interest was remission status, as defined by random GH levels below 2.5 ng/mL and Insulin-like Growth Factor-1 (IGF-1) within the normal range three months post-operation. Results: The proportion of patients with remission three months after surgery was 69.8% with a 95% confidence interval (CI) = 53.9–82.8%. The proportions of residual tumors three months after surgery in the remission and non-remission groups were 10.0% (3/27) and 23.1% (3/10), respectively, but there was no significant difference between these proportions (Fisher's exact test, p = 0.35). In a multivariate logistic regression analysis adjusted for sex and age, remission was associated with the absence of cavernous sinus invasion, with an odds ratio (OR) = 5.2 (95% CI = 1.1–26.5). In addition, remission was also associated with a post-operative GH level < 2.5 ng/mL (OR = 7.4, 95% CI = 1.1–48.0). Conclusion: We report that the proportion of patients with disease remission three months after surgery was high, indicating that microscopic transsphenoidal surgery was efficacious. More studies should be conducted to assess outcomes of various acromegaly treatment methods in the current context of Vietnam.
first_indexed 2024-12-12T18:58:38Z
format Article
id doaj.art-9b0614b8f5034e10a6ff03f9026dcd36
institution Directory Open Access Journal
issn 2214-7519
language English
last_indexed 2024-12-12T18:58:38Z
publishDate 2020-12-01
publisher Elsevier
record_format Article
series Interdisciplinary Neurosurgery
spelling doaj.art-9b0614b8f5034e10a6ff03f9026dcd362022-12-22T00:15:10ZengElsevierInterdisciplinary Neurosurgery2214-75192020-12-0122100811Reappraisal of microscopic microsurgical transsphenoidal surgery for GH-secreting pituitary macroadenoma in patients with acromegaly: Historical data from Vietnam (2010–2013)Ngo Manh Hung0Dong Van He1Vu Duy Kien2Department of Neurosurgery 2, Viet Duc Hospital, Hanoi, Viet Nam; Corresponding author at: Department of Neurosurgery 2, Viet Duc Hospital, Hanoi, Vietnam 40 Trang Thi, Hoan Kiem, Hanoi, Viet Nam.Department of Neurosurgery 1, Viet Duc Hospital, Hanoi, Viet NamOnCare Medical Technology Company Limited, Hanoi, Viet NamObjective: In Vietnam, microscopic transsphenoidal surgery has been implemented to treat acromegaly patients since 2000. However, no specific outcome studies have been conducted. We assess outcomes of this technique and factors associated with remission. Methods: This prospective observational study was conducted in 43 patients with acromegaly resulting from Growth Hormone (GH)-secreting pituitary macroadenoma. The primary outcome of interest was remission status, as defined by random GH levels below 2.5 ng/mL and Insulin-like Growth Factor-1 (IGF-1) within the normal range three months post-operation. Results: The proportion of patients with remission three months after surgery was 69.8% with a 95% confidence interval (CI) = 53.9–82.8%. The proportions of residual tumors three months after surgery in the remission and non-remission groups were 10.0% (3/27) and 23.1% (3/10), respectively, but there was no significant difference between these proportions (Fisher's exact test, p = 0.35). In a multivariate logistic regression analysis adjusted for sex and age, remission was associated with the absence of cavernous sinus invasion, with an odds ratio (OR) = 5.2 (95% CI = 1.1–26.5). In addition, remission was also associated with a post-operative GH level < 2.5 ng/mL (OR = 7.4, 95% CI = 1.1–48.0). Conclusion: We report that the proportion of patients with disease remission three months after surgery was high, indicating that microscopic transsphenoidal surgery was efficacious. More studies should be conducted to assess outcomes of various acromegaly treatment methods in the current context of Vietnam.http://www.sciencedirect.com/science/article/pii/S2214751920303728Microscopic transsphenoidal surgeryAcromegalyPituitary adenomaMacroadenomaVietnam
spellingShingle Ngo Manh Hung
Dong Van He
Vu Duy Kien
Reappraisal of microscopic microsurgical transsphenoidal surgery for GH-secreting pituitary macroadenoma in patients with acromegaly: Historical data from Vietnam (2010–2013)
Interdisciplinary Neurosurgery
Microscopic transsphenoidal surgery
Acromegaly
Pituitary adenoma
Macroadenoma
Vietnam
title Reappraisal of microscopic microsurgical transsphenoidal surgery for GH-secreting pituitary macroadenoma in patients with acromegaly: Historical data from Vietnam (2010–2013)
title_full Reappraisal of microscopic microsurgical transsphenoidal surgery for GH-secreting pituitary macroadenoma in patients with acromegaly: Historical data from Vietnam (2010–2013)
title_fullStr Reappraisal of microscopic microsurgical transsphenoidal surgery for GH-secreting pituitary macroadenoma in patients with acromegaly: Historical data from Vietnam (2010–2013)
title_full_unstemmed Reappraisal of microscopic microsurgical transsphenoidal surgery for GH-secreting pituitary macroadenoma in patients with acromegaly: Historical data from Vietnam (2010–2013)
title_short Reappraisal of microscopic microsurgical transsphenoidal surgery for GH-secreting pituitary macroadenoma in patients with acromegaly: Historical data from Vietnam (2010–2013)
title_sort reappraisal of microscopic microsurgical transsphenoidal surgery for gh secreting pituitary macroadenoma in patients with acromegaly historical data from vietnam 2010 2013
topic Microscopic transsphenoidal surgery
Acromegaly
Pituitary adenoma
Macroadenoma
Vietnam
url http://www.sciencedirect.com/science/article/pii/S2214751920303728
work_keys_str_mv AT ngomanhhung reappraisalofmicroscopicmicrosurgicaltranssphenoidalsurgeryforghsecretingpituitarymacroadenomainpatientswithacromegalyhistoricaldatafromvietnam20102013
AT dongvanhe reappraisalofmicroscopicmicrosurgicaltranssphenoidalsurgeryforghsecretingpituitarymacroadenomainpatientswithacromegalyhistoricaldatafromvietnam20102013
AT vuduykien reappraisalofmicroscopicmicrosurgicaltranssphenoidalsurgeryforghsecretingpituitarymacroadenomainpatientswithacromegalyhistoricaldatafromvietnam20102013